<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00174785</url>
  </required_header>
  <id_info>
    <org_study_id>EFC5555</org_study_id>
    <nct_id>NCT00174785</nct_id>
  </id_info>
  <brief_title>A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation</brief_title>
  <acronym>ATHENA</acronym>
  <official_title>A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the efficacy of dronedarone in preventing cardiovascular hospitalization or death
      from any cause in a population of high-risk patients with atrial fibrillation/atrial flutter
      (AF/AFL).

      To assess that dronedarone is well tolerated in this population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multinational, double-blind, randomized, multi-center,
      placebo-controlled, parallel-group trial evaluating the effects of dronedarone versus placebo
      (ratio 1:1) over a minimum treatment duration of 12 months and a mean follow-up duration of
      1.75 years (in AF/AFL patients). Patients can be included in the study while in atrial
      fibrillation/flutter or in sinus rhythm if conversion has occurred either spontaneously or
      following a procedure such as electrical cardioversion (or overdrive pacing) or
      administration of an antiarrhythmic drug.After randomization all patients will be followed
      until the common study end date; the last patient included in the study will be followed for
      1 year. Visits will be at baseline, after 7 days, after 14 days, after one month, after three
      months and then every three months until end of the study. At each visit patients will be
      asked for the occurrence of hospitalizations or other events since the last visit. The study
      will be monitored by an independent Data Monitoring Committee (DMC) for safety, tolerability
      and efficacy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Hospitalization for Cardiovascular Reason or Death From Any Cause</measure>
    <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death From Any Cause</measure>
    <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Hospitalization for Cardiovascular Reason</measure>
    <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death</measure>
    <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4628</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Atrial Flutter</condition>
  <arm_group>
    <arm_group_label>Dronedarone 400mg bid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dronedarone 400mg tablets twice daily (bid)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>matching placebo tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dronedarone (SR33589)</intervention_name>
    <description>oral administration (tablets)</description>
    <arm_group_label>Dronedarone 400mg bid</arm_group_label>
    <other_name>Multaq®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>oral administration (tablets)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Patients aged 75 years or older (70 years before protocol amendment 1), or patients
             aged at least 70 years (any age before protocol amendment 1) with one or more of the
             following risk factors at baseline:

               -  Hypertension (taking antihypertensive drugs of at least two different classes)

               -  Diabetes

               -  Prior cerebrovascular accident (stroke or transient ischemic attack) or systemic
                  embolism

               -  Left atrium diameter greater than or equal to 50 mm by echocardiography

               -  Left ventricular ejection fraction less than 0.40 by 2D-echocardiography
                  (two-dimensional echocardiography)

          -  2. Availability of one electrocardiogram (ECG) within the last 6 months, showing that
             the patient was or is in AF/AFL

          -  3. Availability of one ECG within the last 6 months, showing that the patient was or
             is in sinus rhythm

        Exclusion Criteria:

        General criteria:

          -  1. Refusal or inability to give informed consent to participate in the study

          -  2. Any non cardiovascular illness or disorder that could preclude participation or
             severely limit survival including cancer with metastasis and organ transplantation
             requiring immune suppression

          -  3. Pregnant women (pregnancy test must be negative) or women of childbearing potential
             not on adequate birth control: only women with a highly effective method of
             contraception [oral contraception or intra-uterine device (IUD)] or sterile can be
             randomized.

          -  4. Breastfeeding women

          -  5. Previous (2 preceding months) or current participation in another clinical trial
             with an investigational drug (under development) or with an investigational device

          -  6. Previous participation in this trial

        Criteria Related to a cardiac condition:

          -  7. Patients in permanent atrial fibrillation

          -  8. Patients in unstable hemodynamic condition such as acute pulmonary edema within 12
             hours prior to start of study medication; cardiogenic shock; treatment with
             intra-venous pressor agents; patients on respirator; congestive heart failure of stage
             NYHA IV (New York Heart Association classification) within the last 4 weeks;
             uncorrected, hemodynamically significant primary obstructive valvular disease;
             hemodynamically significant obstructive cardiomyopathy; a cardiac operation or
             revascularization procedure within 4 weeks preceding randomization

          -  9. Planned major non-cardiac or cardiac surgery or procedures including surgery for
             valvular heart disease, coronary artery bypass graft (CABG) , percutaneous coronary
             intervention (PCI) , or on urgent cardiac transplantation list

          -  10. Acute myocarditis or constrictive pericarditis

          -  11. Bradycardia &lt; 50 bpm and/or PR-interval &gt; 0.28 sec on the last 12-lead ECG

          -  12. Significant sinus node disease (documented pause of 3 seconds or more) or 2nd or
             3rd degree atrioventricular block (AV-block) unless treated with a pacemaker

        Criteria Related to Concomitant Medications:

          -  13. Need of a concomitant medication that is prohibited in this trial, including the
             requirement for Vaughan Williams Class I and III anti-arrhythmic drugs, that would
             preclude the use of study drug during the planned study period

        Criteria Related to Laboratory Abnormalities:

          -  14. Plasma potassium &lt; 3.5 mmol/l (as anti-arrhythmic drugs can be arrhythmogenic in
             patients with hypokalemia, this must be corrected prior to randomization)

          -  15. A calculated Glomerular Filtration Rate (GFR) at baseline &lt;10 ml/min using the
             Cockroft Gault formula
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>International Clinical Development</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bridgewater</city>
        <state>New Jersey</state>
        <zip>08807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>New South Wales</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Diegem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Laval</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Shangaï</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-aventis Administrative Office</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Causeway Bay</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Natanya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Casablanca</city>
        <country>Morocco</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Gouda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Macquarie Park</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Lysaker</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Makati City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Porto Salvo</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Midrand</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bromma</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Megrine</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Guildford Surrey</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>China</country>
    <country>Czech Republic</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Morocco</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Tunisia</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>France</country>
  </removed_countries>
  <link>
    <url>http://www.sanofi-aventis.com</url>
  </link>
  <reference>
    <citation>Hohnloser SH, Connolly SJ, Crijns HJ, Page RL, Seiz W, Torp-Petersen C. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter. J Cardiovasc Electrophysiol. 2008 Jan;19(1):69-73. Epub 2007 Nov 21.</citation>
    <PMID>18031520</PMID>
  </reference>
  <results_reference>
    <citation>Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ; ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778. Erratum in: N Engl J Med. 2009 Jun 4;360(23):2487. N Engl J Med. 2011 Apr 14;364(15):1481.</citation>
    <PMID>19213680</PMID>
  </results_reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <results_first_submitted>July 24, 2009</results_first_submitted>
  <results_first_submitted_qc>November 17, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 23, 2009</results_first_posted>
  <last_update_submitted>January 5, 2010</last_update_submitted>
  <last_update_submitted_qc>January 5, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>International Clinical Development - Study Director</name_title>
    <organization>sanofi-aventis</organization>
  </responsible_party>
  <keyword>Mortality, Hospitalization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amiodarone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment of patients started on June 29, 2005 and was completed on December 30, 2006. The study was conducted at 551 centers in 37 countries. The common study end date ensuring a minimum planned follow-up of one year was December 30th, 2007.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Dronedarone 400mg Bid</title>
          <description>dronedarone tablets 400mg twice daily</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>matching placebo tablets</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2301">randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group</participants>
                <participants group_id="P2" count="2327">randomized patients; among them, 14 patients did not receive any study drug in the placebo group</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1605">completed study drug</participants>
                <participants group_id="P2" count="1611">completed study drug</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="696"/>
                <participants group_id="P2" count="716"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="293"/>
                <participants group_id="P2" count="191"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="173"/>
                <participants group_id="P2" count="175"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Atrial Fibrillation/Flutter recurrence</title>
              <participants_list>
                <participants group_id="P1" count="110"/>
                <participants group_id="P2" count="167"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Prohibited antiarrhythmic medication</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="88"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other prohibited medication</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Family request</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not pre-specified/Not coded</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dronedarone 400mg Bid</title>
          <description>dronedarone tablets 400mg twice daily</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>matching placebo tablets</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2301"/>
            <count group_id="B2" value="2327"/>
            <count group_id="B3" value="4628"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18 to &lt; 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="431"/>
                    <measurement group_id="B2" value="442"/>
                    <measurement group_id="B3" value="873"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>65 to &lt; 75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="923"/>
                    <measurement group_id="B2" value="907"/>
                    <measurement group_id="B3" value="1830"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="947"/>
                    <measurement group_id="B2" value="978"/>
                    <measurement group_id="B3" value="1925"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71.6" spread="8.9"/>
                    <measurement group_id="B2" value="71.7" spread="9.0"/>
                    <measurement group_id="B3" value="71.6" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1131"/>
                    <measurement group_id="B2" value="1038"/>
                    <measurement group_id="B3" value="2169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1170"/>
                    <measurement group_id="B2" value="1289"/>
                    <measurement group_id="B3" value="2459"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>First Hospitalization for Cardiovascular Reason or Death From Any Cause</title>
        <description>The primary event is the first hospitalization for cardiovascular reason or death from any cause, whichever is earlier, as assessed by the investigator. The primary efficacy analysis is performed on the time from randomization to this primary event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
        <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
        <population>All efficacy analyses were performed on the &quot;all randomized patients&quot; population including all patients randomized irrespective of whether the patient actually received any drug or complied with the study protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Dronedarone 400mg Bid</title>
            <description>dronedarone tablets 400mg twice daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo tablets</description>
          </group>
        </group_list>
        <measure>
          <title>First Hospitalization for Cardiovascular Reason or Death From Any Cause</title>
          <description>The primary event is the first hospitalization for cardiovascular reason or death from any cause, whichever is earlier, as assessed by the investigator. The primary efficacy analysis is performed on the time from randomization to this primary event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
          <population>All efficacy analyses were performed on the &quot;all randomized patients&quot; population including all patients randomized irrespective of whether the patient actually received any drug or complied with the study protocol.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2301"/>
                <count group_id="O2" value="2327"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="734"/>
                    <measurement group_id="O2" value="917"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Cumulative incidence functions in each treatment group were calculated using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. The primary comparison was performed at the 5% level using a 2-sided Log rank test.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.69</ci_lower_limit>
            <ci_upper_limit>0.84</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of first hospitalization for cardiovascular reason or death for the dronedarone group compared with the placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death From Any Cause</title>
        <description>The considered event is death from any cause. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
        <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
        <population>«All randomized patients» population</population>
        <group_list>
          <group group_id="O1">
            <title>Dronedarone 400mg Bid</title>
            <description>dronedarone tablets 400mg twice daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo tablets</description>
          </group>
        </group_list>
        <measure>
          <title>Death From Any Cause</title>
          <description>The considered event is death from any cause. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
          <population>«All randomized patients» population</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2301"/>
                <count group_id="O2" value="2327"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                    <measurement group_id="O2" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.18</p_value>
            <p_value_desc>Cumulative incidences calculated in each group using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. Hierarchical procedure applied to secondary efficacy endpoints testing to protect the global type I error.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>1.08</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of death from any cause for the dronedarone group compared with the placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Hospitalization for Cardiovascular Reason</title>
        <description>The considered event is the first hospitalization for cardiovascular reason, as assessed by the Investigator. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
        <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
        <population>«All randomized patients» population</population>
        <group_list>
          <group group_id="O1">
            <title>Dronedarone 400mg Bid</title>
            <description>dronedarone tablets 400mg twice daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo tablets</description>
          </group>
        </group_list>
        <measure>
          <title>First Hospitalization for Cardiovascular Reason</title>
          <description>The considered event is the first hospitalization for cardiovascular reason, as assessed by the Investigator. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
          <population>«All randomized patients» population</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2301"/>
                <count group_id="O2" value="2327"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="675"/>
                    <measurement group_id="O2" value="859"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Cumulative incidences calculated in each group using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. Hierarchical procedure applied to secondary efficacy endpoints testing to protect the global type I error.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.67</ci_lower_limit>
            <ci_upper_limit>0.82</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of first hospitalization for cardiovascular reason for the dronedarone group compared with the placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Death</title>
        <description>The considered event is cardiovascular death, as assessed by the Investigator. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
        <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
        <population>«All randomized patients» population</population>
        <group_list>
          <group group_id="O1">
            <title>Dronedarone 400mg Bid</title>
            <description>dronedarone tablets 400mg twice daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo tablets</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Death</title>
          <description>The considered event is cardiovascular death, as assessed by the Investigator. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
          <population>«All randomized patients» population</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2301"/>
                <count group_id="O2" value="2327"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.025</p_value>
            <p_value_desc>Cumulative incidences calculated in each group using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. Hierarchical procedure applied to secondary efficacy endpoints testing to protect the global type I error.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.70</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.51</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of cardiovascular death for the dronedarone group compared with the placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Adjudicated Cardiovascular Death</title>
        <description>The considered event is cardiovascular death, as assessed by the blinded adjudication of the Steering Committee. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
        <time_frame>minimum follow-up duration: 1 year ; maximum: 2.5 years</time_frame>
        <population>«All randomized patients» population</population>
        <group_list>
          <group group_id="O1">
            <title>Dronedarone 400mg Bid</title>
            <description>dronedarone tablets 400mg twice daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo tablets</description>
          </group>
        </group_list>
        <measure>
          <title>Adjudicated Cardiovascular Death</title>
          <description>The considered event is cardiovascular death, as assessed by the blinded adjudication of the Steering Committee. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period.</description>
          <population>«All randomized patients» population</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2301"/>
                <count group_id="O2" value="2327"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <p_value_desc>Cumulative incidences calculated in each group using non-parametric Kaplan-Meier estimates. Median time-to-event was not reached in any group. The comparison was performed at the 5% level using a 2-sided Log rank</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.51</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
            <estimate_desc>The hazard ratio was estimated by a Cox's proportional hazard model with treatment arm factor. It represents the relative hazard of adjudicated cardiovascular death for the dronedarone group compared with the placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>In both treatment groups, the median duration of exposure was about 18 months, with a maximum of 30 months.</time_frame>
      <desc>Reported Events are Treatment-Emergent Adverse Events with an onset date between the first study drug intake and the last study drug intake + 10 days and any pre-treatment adverse event that led to study drug permanent discontinuation.</desc>
      <group_list>
        <group group_id="E1">
          <title>Dronedarone 400mg Bid</title>
          <description>dronedarone tablets 400mg twice daily</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>matching placebo tablets</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="456" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="489" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anaemia macrocytic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anaemia of malignant disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Spontaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anaemia haemolytic autoimmune</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anaemia of chronic disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Torsade de pointes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ventricle rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Aortic valve calcification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ventricular flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Inner ear disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Basedow's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Adrenal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Inappropriate antidiuretic hormone secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Open angle glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Maculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ulcerative keratitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Myopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ocular retrobulbar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Optic ischaemic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pterygium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Mallory-weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Thrombosis mesenteric vessel</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Femoral hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Infrequent bowel movements</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Intestinal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lumbar hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Mouth haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oesophageal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oesophageal spasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oesophagitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Reflux oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hiatus hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Intussusception</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Mesenteric artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Mesenteric occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oedematous pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Short-bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Drowning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Implant site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Injection site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cytolytic hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Sarcoidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Mastitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abscess oral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Clonorchiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Encephalitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Epstein-barr virus infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hepatitis a</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Infected epidermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Opisthorchiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Osteomyelitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pancreatitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Peritoneal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Wound infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Obstructive chronic bronchitis with acute exacerbation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bursitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Groin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hiv infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Peridiverticular abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Peritonsillar abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pneumonia legionella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pyothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Tinea cruris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Therapeutic agent toxicity</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pubic rami fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Traumatic arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anastomotic complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Asbestosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Medical device pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Postoperative heterotopic calcification</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Transfusion reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dislocation of joint prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Arterial injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Device migration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Graft thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Penetrating abdominal trauma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Spinal cord injury cervical</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Traumatic arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Electrocardiogram qt prolonged</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cardioactive drug level increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Coagulation test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>International normalised ratio decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Prothrombin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hepatitis c positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vitamin b12 deficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis acquired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Sympathetic posterior cervical syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Intervertebral disc compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Neck mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Spondylolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of thyroid gland</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bronchioloalveolar carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour pulmonary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Metastatic carcinoma of the bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Myeloproliferative disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Nasal cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Thymoma malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Urethral adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ovarian adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Benign peritoneal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Breast cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Breast cancer stage iii</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Inflammatory carcinoma of the breast</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Large intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ocular neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Papillary serous endometrial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Plasmacytoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pleura carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Tumour ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vulval cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dementia alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Brain mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pseudobulbar palsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Amyotrophic lateral sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Guillain-barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Mononeuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Generalised anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Delirium tremens</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bladder obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cystitis noninfective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Acquired hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Breast discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Penis disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Adnexa uteri cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Nasal turbinate hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Bronchopneumopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Panniculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Photodermatosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dermatitis bullous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Victim of crime</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Ileostomy closure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Shoulder arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Suprapubic catheter insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Transurethral prostatectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Pilonidal sinus repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Femoral arterial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Iliac artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (10.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1584" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="1527" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Any cardiac disorders</sub_title>
                <counts group_id="E1" subjects_affected="251" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="213" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Any Gastrointestinal disorders</sub_title>
                <counts group_id="E1" subjects_affected="573" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="478" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="222" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="142" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="122" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Any general disorders and administration site conditions</sub_title>
                <counts group_id="E1" subjects_affected="397" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="348" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="147" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="119" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="115" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Any infections and infestations</sub_title>
                <counts group_id="E1" subjects_affected="508" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="533" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Any injury, poisoning and procedural complications</sub_title>
                <counts group_id="E1" subjects_affected="187" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="198" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Any investigation disorders</sub_title>
                <counts group_id="E1" subjects_affected="298" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="199" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Any metabolism and nutrition disorders</sub_title>
                <counts group_id="E1" subjects_affected="171" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="183" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Any musculoskeletal and connective tissue disorders</sub_title>
                <counts group_id="E1" subjects_affected="364" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="376" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Any nervous system disorders</sub_title>
                <counts group_id="E1" subjects_affected="362" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="365" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="160" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="145" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Any psychiatric disorders</sub_title>
                <counts group_id="E1" subjects_affected="106" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="125" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Any respiratory, thoracic and mediastinal disorders</sub_title>
                <counts group_id="E1" subjects_affected="315" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="318" subjects_at_risk="2313"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="120" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="96" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Any skin and subcutaneous tissue disorders</sub_title>
                <counts group_id="E1" subjects_affected="235" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="174" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Any vascular disorders</sub_title>
                <counts group_id="E1" subjects_affected="179" subjects_at_risk="2291"/>
                <counts group_id="E2" subjects_affected="187" subjects_at_risk="2313"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such publication for comment at least 45 days before any submission for publication. If requested by the Sponsor, any submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>International Clinical Development (ICD), Clinical Study Director</name_or_title>
      <organization>sanofi-aventis</organization>
      <email>GV-Contact-us@sanofi-aventis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

